The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients

Condition:   Dermatomyositis, Adult Type Intervention:   Drug: JAK Inhibitor Sponsor:   First Affiliated Hospital Xi'an Jiaotong University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials